Form 4: ResMed Chief Product Officer Sells 6,160 Shares

ResMed's Chief Product Officer, Justin Leong, sold 6,160 shares of company stock at an average price of $243.087.

Summary

• Justin Leong, the Chief Product Officer of ResMed Inc., sold 6,160 shares of ResMed common stock on November 22, 2024.
• The sale was executed in multiple trades with prices ranging from $243.00 to $243.315 per share.
• The weighted average sale price was $243.087 per share.
• Following the transaction, Mr. Leong directly owns 21,718 shares of ResMed common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a common occurrence and doesn't inherently indicate positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of key personnel.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, such as ResMed, and are required by the SEC.
• Similar filings are made by executives at comparable companies like Philips and Fisher & Paykel Healthcare when they trade their company's stock.

Stakeholder Impact

• The stock sale by a company executive may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial performance.

Key Dates

Keywords

ResMed, insider trading, stock sale, Justin Leong, Chief Product Officer, RMD